Indications and uses
Feline Tape Tabs (praziquantel tablets) will remove the common tapeworms, Dipylidium caninum and Taenia taeniaeformis , from cats and kittens.
Feline Tape Tabs (praziquantel tablets) will remove the common tapeworms, Dipylidium caninum and Taenia taeniaeformis , from cats and kittens.
Feline Tape Tabs (praziquantel tablets) may be given directly in the mouth or crumbled and mixed with the food. Administer to cats and kittens* only as follows: *Not intended for use in kittens less than 6 weeks of age. Body Weight (lbs) No. of Tablets 4 pounds and under ½ tablet 5-11 pounds 1 tablet Over 11 pounds 1 ½ tablets FASTING IS NEITHER NECESSARY NOR RECOMMENDED.
Store at less than or equal to 25°C (77°F). durvet Mfd. for: Durvet, Inc. 100 S.E. Magellan Drive Blue Springs, MO 64014 www.durvet.com ISS25XB06 Approved by FDA under NADA # 111-798 Made in China PA104399X July 2025
durvet
Feline
Tape Tabs™
(praziquantel tablets) FOR CATS
Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.
Consult your veterinarian before administering the tablets to weak or debilitated animals.
Each tablet contains 23 mg praziquantel.
Feline Tape Tabs (praziquantel tablets) are sized for easy oral administration to either adult cats or kittens. The tablets may be crumbled and mixed with the feed.
Feline Tape Tabs (praziquantel tablets) will remove the common tapeworms, Dipylidium caninum and Taenia taeniaeformis, from cats and kittens.
Feline Tape Tabs (praziquantel tablets) may be given directly in the mouth or crumbled and mixed with the food. Administer to cats and kittens* only as follows:
| *Not intended for use in kittens less than 6 weeks of age. | |
Body Weight (lbs) | No. of Tablets |
4 pounds and under | ½ tablet |
5-11 pounds | 1 tablet |
Over 11 pounds | 1 ½ tablets |
FASTING IS NEITHER NECESSARY NOR RECOMMENDED.
Steps should be taken to control fleas and rodents on the premises in order to prevent reinfection; otherwise, retreatment will be necessary. This is especially true in cases of tapeworms transmitted by fleas (Dipylidium caninum) where reinfection is almost certain to occur if fleas are not removed from the animal and its environment. If reinfection occurs, tapeworm segments may be observed within one month of the initial treatment.
Isolated incident of either salivation or diarrhea have been reported following treatment, but were considered non-significant. If these signs are observed and they persist, consult your veterinarian.
Questions? For product questions, to report side effects, or for a copy of the Safety Data Sheet (SDS), call Durvet, Inc. at 1-800-821-5570.
For additional information about reporting side effects for animal drugs, contact FDA at 1-888-FDA-VETS or
www.fda.gov/animal-veterinary/report-problem/how-report-animal-drug-and-device-side-effects-and-product-problems.
Keep out of the reach of children.
Not for human use.
Bottle of 3 scored tablets. Each scored tablet contains 23 mg praziquantel.
Store at less than or equal to 25°C (77°F).
durvet
Mfd. for: Durvet, Inc.
100 S.E. Magellan Drive
Blue Springs, MO 64014
www.durvet.com
ISS25XB06
Approved by FDA under NADA # 111-798
Made in China
PA104399X July 2025
Feline
Tape Tabs™
(praziquantel tablets) FOR CATS
CONTAINS
3 TABLETS
EACH TABLET CONTAINS:
23 mg praziquantel
WARNING: KEEP OUT OF REACH OF
CHILDREN. NOT FOR HUMAN USE.

Feline
Tape Tabs™
(praziquantel tablets)
FOR CATS
Tapeworm Tablet
for Cats
3
TABLETS
EACH TABLET
CONTAINS:
23 mg praziquantel
durvet
WARNING: KEEP OUT OF REACH OF
CHILDREN. NOT FOR HUMAN USE.

| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Data code | Data Matrix | SH104399X | image-02.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 8cabd598-669e-43ab-9753-4aec00a484cb | Product name | 1 | 20180125 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 30798-200 | 30798-200-62 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PRAZIQUANTEL | 6490C9U457 | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2022-12-21 | full-release | 2026-06-01 02:41:48 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PRAZIQUANTEL | PRAZIQUANTEL | Par Health USA, LLC | 16f2b9c4-a260-4a31-bd52-e5945913246c | 2026-08-12 | Warnings, Adverse reactions | PRAZIQUANTEL |
| Biltricide | PRAZIQUANTEL | Bayer HealthCare Pharmaceuticals Inc. | 34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9 | 2026-03-02 | Warnings, Adverse reactions | PRAZIQUANTEL |
Adverse event summaries are temporarily unavailable. Other product information remains available.